分组1 - BioHarvest Sciences Inc. reported a quarterly loss of $0.14 per share, which is an improvement from a loss of $0.16 per share a year ago, aligning with the Zacks Consensus Estimate [1] - The company posted revenues of $9.07 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.74%, but showing an increase from $6.54 million year-over-year [2] - The stock has increased approximately 27.8% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] 分组2 - The earnings outlook for BioHarvest Sciences Inc. is uncertain, with current consensus EPS estimates at -$0.09 for the coming quarter and -$0.59 for the current fiscal year [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 35% of over 250 Zacks industries, indicating a favorable industry outlook [8] - The estimate revisions trend for BioHarvest Sciences Inc. was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it will perform in line with the market [6]
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Lags Revenue Estimates